|
| Status |
Public on Dec 31, 2022 |
| Title |
Orthotopic KI tumors treated with vehicle or IRAK4 inhibitor CA-4948 for two weeks |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
We treated FVBN/J mice bearing orthotopic KI tumors with vehicle or CA-4948 for two weeks and performed bulk RNASeq to assess transcriptomic changes in the tumor
|
| |
|
| Overall design |
Bulk RNAseq analysis of vehicle and CA-4948 treated orthotopic KI tumors. 4 animals per condition.
|
| |
|
| Contributor(s) |
Lim K |
| Citation(s) |
35271824 |
| NIH grant(s) |
| Grant ID |
Grant title |
Affiliation |
Name |
| R37 CA219697 |
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA |
WASHINGTON UNIVERSITY |
Kian H Lim |
|
| |
| Submission date |
Feb 23, 2022 |
| Last update date |
Apr 01, 2023 |
| Contact name |
Kian-Huat Lim |
| E-mail(s) |
[email protected]
|
| Phone |
3143627009
|
| Organization name |
Washington University School of Medicine
|
| Department |
Internal Medicine/Oncology
|
| Street address |
4566 Scott Avenue, Room 502
|
| City |
St. Louis |
| State/province |
MO |
| ZIP/Postal code |
63132 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL17021 |
Illumina HiSeq 2500 (Mus musculus) |
|
| Samples (8)
|
|
| Relations |
| BioProject |
PRJNA809752 |
Less...
More...